2507 (2507) Fair Value & Analysis

Industrials · Market cap HK$12.7B

2 2507 2507 · HK

PriceHK$34.72

Fair ValueHK$7.97

Upside-77.0%

Quality37/100

Watch 2507 for free — get notified when fair value or trend changes. Watch for free

Evidence: High Range HK$4.82 – HK$9.96

Fair value as of: Jul 2, 2026

From 26 valuation models · updated today

Share price −5.3% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$30.42 – HK$71.35 · fair‑value band HK$4.82 – HK$9.96 · the HK$34.72 price screens above the HK$7.97 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

2507 (2507) currently trades at HK$34.72, while our model-based Fair Value estimate is HK$7.97 — implying the stock looks roughly 77.0% overvalued today. We read business quality at 37/100 (below-average quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

Over the trailing twelve months, 2507 generated revenue of HK$1.4B at a net margin of 10.3%. Revenue grew 5.3% year over year. It earns a return on equity of 16.7%. The balance sheet holds a net cash position of HK$249M. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$1.4B

Revenue growth (YoY) +5.3%

Net margin 10.3%

Return on equity 16.7%

Free cash flow HK$74.4M FY2025

P/E ratio 11.7

More key figures

Operating margin 11.3%

EPS (TTM) HK$0.1800

Dividend yield 0.4%

EPS growth (YoY) -14.0%

Net cash HK$249M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

2507 reported revenue of HK$1.4B in FY2025 versus HK$738M in FY2021, a compound +16.4%/yr. Reported net income was HK$139M in FY2025, compounding +17.7%/yr from FY2021.

Revenue +16.4%/yr

FY21 HK$738M

FY22 HK$894M

FY23 HK$1.1B

FY24 HK$1.2B

FY25 HK$1.4B

Net income +17.7%/yr

FY21 HK$72.4M

FY22 HK$88.1M

FY23 HK$91.1M

FY24 HK$121M

FY25 HK$139M

Is 2507 fairly valued? → Check now

Similar stocks

6 more Aerospace & Defense stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock	Price	Fair Value	vs Fair Value
General Electric Company GE	C$46.59	C$11.06	-76%
RTX Corporation RTX	$177.41	$102.41	-42%
The Boeing Company BCO	€198.20	€51.07	-74%
Airbus SE EADSF	$217.43	$138.69	-36%
Safran SA SAFRY	$94.54	$57.23	-39%
Rolls-Royce Holdings RYCEY	$18.79	$9.46	-50%

Explore undervalued stocks

More undervalued Industrials stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 2507 (2507) undervalued?

As of Jul 2, 2026, our model estimates a fair value of HK$7.97 versus a price of HK$34.72 — about −77% (overvalued). Model-based estimate, not financial advice.

What is the fair value of 2507?

Our model-based fair value for 2507 is HK$7.97 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$34.72.

What is the quality score of 2507?

2507 has a Quality Score of 37/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 2507 (2507)?

2507 reported trailing-twelve-month revenue of about HK$1.4B (latest available figure, as of Jul 2, 2026).

What is the net profit margin of 2507?

The net profit margin of 2507 is about 10.3%, meaning it keeps roughly 10.3% of revenue as net income. Based on the latest reported figures.

Does 2507 pay a dividend?

2507 currently shows a dividend yield of about 0.36% relative to its recent price (as of Jul 2, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.